— Know what they know.
Not Investment Advice
Also trades as: SOM.AX (ASX) · $vol 0M

SOMNF OTC

SomnoMed Limited
1W: +0.0% 1M: -46.7% 3M: -46.7% YTD: -52.9% 1Y: -45.5% 3Y: -45.5% 5Y: -86.0%
$0.24
-0.00 (-0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 36 · $52.7M mcap · 169M float · 0.0000% daily turnover · Short 77% of daily vol

Balance Sheet Trends

Total Assets
$75M -7.5% ▼
5Y CAGR: +5.9%
Total Liabilities
$28M -20.3% ▼
5Y CAGR: +2.8%
Shareholders Equity
$47M +2.0% ▲
5Y CAGR: +8.0%
Cash & Investments
$17M -0.8% ▼
5Y CAGR: -4.1%
Total Debt
$5M -32.1% ▼
5Y CAGR: -9.4%
Net Debt
-$12M -26.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$16M$12M$16M$17M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$16M$12M$16M$17M$17M
Net Receivables$9M$9M$8M$11M$12M
Inventory$3M$4M$6M$7M$7M
Other Current Assets$268K$315K$315K$3M$0
Total Current Assets$30M$27M$35M$43M$39M
Property, Plant & Equip.$9M$13M$11M$14M$12M
Goodwill & Intangibles$21M$25M$20M$9M$22M
Long-Term Investments$264K$40K$0$0$58K
Other Non-Current Assets-$6M-$6M$57K$15M$0
Total Non-Current Assets$28M$35M$35M$38M$36M
Total Assets$58M$62M$70M$81M$75M
— Liabilities —
Accounts Payable$13M$12M$13M$19M$6M
Short-Term Debt$5M$313K$307K$344K$2M
Deferred Revenue$1M$233K$0$0$45K
Other Current Liabilities$985K$780K$2M$3M$11M
Total Current Liabilities$24M$18M$20M$29M$23M
Long-Term Debt$2M$16M$709K$449K$311K
Other Non-Current Liab.$1M$787K$720K$810K$1M
Total Non-Current Liabilities$7M$22M$5M$6M$4M
Total Liabilities$30M$40M$25M$35M$28M
— Equity —
Common Stock$74M$74M$110M$120M$112M
Retained Earnings-$54M-$62M-$75M-$78M-$81M
Accumulated OCI$8M$10M$9M$4M$16M
Total Stockholders Equity$28M$22M$45M$46M$47M
Total Liabilities & Equity$58M$62M$70M$81M$75M
— Key Metrics —
Total Debt$12M$24M$7M$8M$5M
Net Debt-$4M$12M-$9M-$9M-$12M
Total Investments$264K$40K$0$0$58K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms